Phosphatidylserine inhibits NFκB and p38 MAPK activation in human monocyte derived dendritic cells

21Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Phosphatidylserine (PS) is an anionic phospholipid restricted to the inner surface of the plasma membrane. PS translocates to the cell surface during early apoptosis where it serves as a marker for rapid uptake by phagocytes. PS is also thought to regulate immune responses. Dendritic cells (DC) are the most potent antigen presenting cells. Previous studies demonstrated that PS inhibits the expression of MHC and co-stimulatory molecules, the secretion of IL-12p70, and the ability to activate T cells by human monocyte derived DCs. However, the cell signaling mechanisms by which PS regulated DCs are not well described. In the current study we tested the effects of PS on signal transduction pathways thought to regulate human myeloid DC maturation and IL-12p70 production. We showed that PS inhibited the activation of nuclear factor-κB (NFκB) in response to LPS by preventing IκBα phosphorylation and degradation. PS also increased the total IκBα levels in immature DCs and inhibited p38 mitogen activated protein kinase (MAPK) phosphorylation and activation. The findings suggest a possible mechanism for regulating the immunostimulatory function of DCs by PS. © 2011 Elsevier Ltd.

Cite

CITATION STYLE

APA

Doffek, K., Chen, X., Sugg, S. L., & Shilyansky, J. (2011). Phosphatidylserine inhibits NFκB and p38 MAPK activation in human monocyte derived dendritic cells. Molecular Immunology, 48(15–16), 1771–1777. https://doi.org/10.1016/j.molimm.2011.04.021

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free